Zepym Health

Medical Disclaimer

Last updated

1.This Is Not Emergency Care

If you are experiencing a medical emergency, including chest pain, suicidal thoughts, signs of stroke, severe allergic reaction, or any life-threatening symptom, call 911 or go to your nearest emergency room immediately. Do not use the Zepym Health platform for emergencies.

2.Educational Content Is Not Medical Advice

Marketing pages, blog posts, FAQs, and other public content on Zepym Health are educational in nature and do not constitute medical advice. Always speak with a qualified Clinician before starting, stopping, or changing any treatment.

3.No Physician–Patient Relationship Until Acceptance

Browsing this website, completing an intake form, or submitting payment does not create a physician–patient relationship. A clinical relationship begins only after a licensed Clinician with the Affiliated Medical Group has reviewed your intake and affirmatively accepted you for evaluation or treatment.

4.Individual Results Vary

Weight loss and other health outcomes depend on many factors, including genetics, metabolism, treatment adherence, diet, physical activity, and pre-existing conditions. Patient testimonials and success stories featured on the Service reflect individual experiences and are not a guarantee or prediction of your results. Some patients may experience little or no benefit and some may experience adverse effects.

5.Telehealth Informed Consent

Care provided through Zepym Health is delivered by telehealth (secure messaging, video, and asynchronous review). Telehealth has benefits (convenience, access, privacy) and limitations (no in-person physical exam, potential technology failures, limited ability to manage urgent issues). By using the Service you acknowledge these benefits and limitations and consent to receive care by telehealth. You may withdraw consent at any time and seek in-person care.

Your Clinician may determine that telehealth is not appropriate for your situation and may refer you to in-person care. You are responsible for following any such referral.

6.GLP-1 Risks & Boxed Warning

Boxed Warning — GLP-1 Receptor Agonists

GLP-1 receptor agonists, including semaglutide and tirzepatide, carry a boxed warning regarding the risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). These medications are contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and the symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness).

Additional risks may include pancreatitis, acute gallbladder disease, acute kidney injury, hypoglycemia (especially in patients on insulin or sulfonylureas), hypersensitivity reactions, diabetic retinopathy complications, and others. Discuss your full medical history with your Clinician before starting therapy.

7.Contraindications

You should not use GLP-1 receptor agonist therapy if any of the following applies, unless specifically directed by your Clinician with full knowledge of your history: personal or family history of medullary thyroid carcinoma; MEN 2 syndrome; prior serious hypersensitivity to a GLP-1 agonist; history of pancreatitis (relative contraindication); pregnancy, planning pregnancy, or breastfeeding; severe gastrointestinal disease including gastroparesis; or end-stage renal disease without specialist oversight.

8.Common Adverse Effects

Common adverse effects of GLP-1 therapy include nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, fatigue, headache, and injection-site reactions. Most effects are mild to moderate and improve with time and dose adjustment. Contact your Clinician promptly for severe or persistent symptoms, severe abdominal pain (which may indicate pancreatitis), or signs of dehydration.

9.Compounded Medications

In some cases your Clinician may prescribe a compounded medication prepared by a state-licensed compounding pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. Compounding may be appropriate when a commercially available product does not meet a specific clinical need. Your Clinician will discuss the risks and benefits of any compounded therapy with you.

10.State Licensing & Scope of Practice

The Affiliated Medical Group’s Clinicians are licensed in specific U.S. states. The practice of medicine is governed by the laws of the state where you are located at the time of the encounter. If you relocate, notify us — we may not be able to continue your care in states where our Clinicians are not licensed.

11.No Responsibility for Third-Party Information

Zepym Health is not responsible for the content of any third-party website, study, or product referenced on the Service. Mention of a product, service, or organization does not constitute endorsement.

Zepym Health

Your partner in specialty care. Doctor-led treatments delivered safely and discreetly, completely online.

Important Medical Disclaimer

Emergencies. This service does not replace emergency medical care. If you have a medical emergency, call 911 or go to the nearest emergency room immediately.

No physician–patient relationship from intake alone. The assessment available on the Zepym Health website does not, by itself, create a physician–patient relationship between the individual completing the assessment and Zepym Health or its Affiliated Medical Group. Clinicians of the Affiliated Medical Group adhere to clinical protocols designed for patient safety and use exclusionary criteria to determine whether an individual is not a candidate for GLP-1 therapy. Answers provided in the assessment may screen an individual out of eligibility. A licensed Clinician will review your intake after checkout to determine whether you qualify for a prescription. Clinicians retain sole authority over the decision to prescribe.

Customer claims & individual results. Claims and benefits referenced on this website refer to self-reported data from customers on a treatment plan that includes GLP-1 medications and consultations with medical professionals. Customers reported their weight on the initial intake and approximately every 3–4 weeks thereafter. Results may vary and are affected by adherence to the program and Clinician recommendations. Inches lost from hips, waist, chest, thighs and arms, where mentioned, are not typical and reflect individuals who also followed a reduced-calorie diet and regular exercise. Consult a healthcare professional before using any medication or beginning a weight-loss program.

Compounded medications. Compounded medications are not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Where clinically appropriate, a licensed Clinician may prescribe a compounded medication prepared by a state-licensed compounding pharmacy operating under Section 503A. A compounded medication is only prescribed when a Clinician determines it is medically appropriate, based on a telehealth consultation and your medical history. Nothing on this website is intended to state or imply that any compounded medication is FDA-approved, proven, or guaranteed to be safe or effective. We encourage prospective users to discuss the specific risks and benefits with their Clinician. Zepym Health does not manufacture compounded medications, and you may receive medication that looks different than what is depicted on the website.

Pricing & coverage. The initial assessment is free for end users. Eligibility for insurance reimbursement or copay assistance is determined at the time of the visit and is not guaranteed.

Pharmacy partners. Zepym Health partners with U.S.-licensed pharmacies to dispense and ship medications. Our team coordinates regularly with these partners regarding inventory, shipping, and medication testing.

Medication & trademarks. Where included, medication is part of the cost of the Zepym Health program. All third-party trademarks, service marks, and trade names are the property of their respective owners and are not affiliated with Zepym Health. Medical treatment is provided by the Affiliated Medical Group and its independently contracted Clinicians.

State licensing. Care is delivered only in U.S. states where the Affiliated Medical Group’s Clinicians are licensed. The practice of medicine is governed by the laws of the state where the patient is located at the time of the encounter.

AI-assisted content. Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence. No representation or warranty is made regarding the accuracy or completeness of such content. Individuals appearing in advertisements may be actors or models.

Testimonials. Testimonials on this website are from Zepym Health patients. To protect patient privacy, images representing those testimonials may use models. No data, photos, claims or other information shown are derived from clinical trials, studies or public information and are not always representative of the Zepym Health patient experience.

Verify Approval for www.zepym.com